Testing effectiveness (Phase 2)Study completedNCT00001662
What this trial is testing
Treatment of Alzheimer's Disease With CX516 (Ampalex)
Who this might be right for
Alzheimer's DiseaseDementia
National Institute of Neurological Disorders and Stroke (NINDS) 40